Navigation Links
Laureate Pharma Appoints Gary Swan as Vice President of Operations
Date:2/14/2008

- Augments Senior Management Team with more than 30 Years Experience in

Biopharmaceutical Manufacturing, Engineering, Technical Services and

Validation -

PRINCETON, N.J., Feb. 14 /PRNewswire/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced the appointment of Gary Swan as Vice President of Operations. In this newly created position, Mr. Swan will be responsible for leading Laureate's manufacturing operations, which include upstream processing, downstream processing, formulation and filling, facilities maintenance, warehouse operations, and environmental, health and safety regulations.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080131/NETH020LOGO )

"We are delighted to welcome Gary to Laureate's senior leadership team," said Robert J. Broeze, Ph.D., President and CEO of Laureate. "With his strong background and extensive experience of more than 30 years in biopharmaceutical manufacturing operations, Gary will play a key leadership role in driving and managing Laureate's tremendous growth."

Gary's experience includes biopharmaceutical manufacturing, engineering, technical services, validation, and quality control. Most recently, Gary held the position of Senior Director of Manufacturing at Nastech Pharmaceuticals in Hauppauge, NY, a publicly traded biopharmaceutical company developing innovative products based on proprietary molecular biology-based drug delivery technologies. At Nastech, Gary directed the operations at two manufacturing sites in New York and Washington. In this capacity, he also led the planning and scheduling of the production of R&D, clinical, and licensed products. Prior to Nastech, Gary was the Vice President of Operations at VI Technologies in Melville, NY, a publicly traded biopharmaceutical company with a focus on development and manufacturing of virus-inactivated blood products and the purification of proteins from blood components. At VI, Gary was responsible for strategic planning and daily operation of a 100,000 SF sterile product biopharmaceutical facility with a staff of 200. Gary has a BS in Biology from Auburn University, Auburn, AL.

About Laureate Pharma, Inc.

Laureate Pharma is a full-service biopharmaceutical development and protein production company located in Princeton, New Jersey. Laureate Pharma offers superior bioprocessing services that accelerate new products from development through production. Laureate provides a wide range of specialized services from process design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. Laureate Pharma, Inc. is a partner company of Safeguard Scientifics, Inc. (NYSE: SFE; http://www.safeguard.com), which provides growth capital for entrepreneurial and innovative technology and life sciences companies through expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400 or info@laureatepharma.com, or visit http://www.laureatepharma.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
2. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
3. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
4. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
5. Pharmaxis to Apply to Market Bronchitol in Australia
6. Marketing and Meeting Details (M2D) Offers Customized Convention Registration and Management Tool to Clients Inside and Outside of Pharma/Biotech
7. Vion Pharmaceuticals Holds Special Meeting of Stockholders
8. Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
9. Addressing the Pharmacist Shortage: Medco Labor Coalition(TM) Launches National Scholarship Program to Support the Development of the Next Generation of Pharmacists
10. Cellegy Pharmaceuticals Announces Signing of Definitive Merger Agreement
11. Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... Philadelphia, PA (PRWEB) , ... May 19, 2017 ... ... for its QED Proof-of-Concept Program. Academic researchers with technologies ripe for commercialization, ... Pennsylvania, New Jersey and Delaware, are encouraged to submit proposals. QED, now in ...
(Date:5/18/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that Richard Kenley, ... Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm as an Expert ... Chief Operating Officer at Anaborex, Senior VP and General Manager of the San Diego ...
(Date:5/18/2017)... ... May 17, 2017 , ... HOLLOWAY AMERICA, a leading manufacturer ... dairy, munitions, and pharmaceutical/biotech, recently introduced The Revolution Lift™, a new precision-controlled head ... in technology comes on the heels of HOLLOWAY’s release of the intelliVessel™, a ...
(Date:5/16/2017)... ... 16, 2017 , ... Genedata, a leading provider of advanced ... Group Meetings, which will be held in Boston, Cambridge/UK, Shanghai, and Tokyo. These ... data analysis and learn about the latest advances in screening technologies and applications. ...
Breaking Biology Technology:
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:3/30/2017)... March 30, 2017  On April 6-7, 2017, Sequencing.com ... Genome hackathon at Microsoft,s headquarters in ... will focus on developing health and wellness apps that ... Hack the Genome is the first hackathon for ... world,s largest companies in the genomics, tech and health ...
(Date:3/28/2017)... , March 28, 2017 ... Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video ... and Region - Global Forecast to 2022", published by ... in 2016 and is projected to reach USD 75.64 ... 2017 and 2022. The base year considered for the ...
Breaking Biology News(10 mins):